米索前列醇结合催产素预防产后出血的临床效果观察

Observation of Clinical Effect of Misoprostol Combined with Oxytocin in Preventing Postpartum Hemorrhage

目的:探究米索前列醇协同催产素应用对产后出血患者实施治疗期间的成效。方法:抽取2014年4月~2017年3月来某院就诊的产后出血患者98例,分成两组,对照组49例借用催产素开展治疗,试验组49例借用米索前列醇协同催产素开展治疗,并探究两组患者的第三产程时长与产后出血总量、不良反应的发生率等。结果:比较表明试验组经治疗以后第三产程时长与产后出血总量、不良反应的发生率都好于对照组(P<0.05)。结论:米索前列醇协同催产素应用对产后出血患者实施治疗期间具备极为良好的成效,值得大力推行及应用。

Objective：To investigate the effectiveness of misoprostol combined with oxytocin in the treatment of postpartum hemorrhage.Methods：98 cases of patients with postpartum hemorrhage treated in a hospital from April 2014 to March 2017 were selected and divided into two groups：49 cases in a control group using oxytocin for treatment,49 cases in the treatment group using misoprostol combined with oxytocin for treatment,and investigate the third labor time of two groups of patients and the total amount of postpartum hemorrhage volume,the incidence of adverse reactions,etc.Results：The comparison showed that the total amount of postpartum haemorrhage and the incidence of adverse effects after treatment was better than that of the control group and P〈0.05.Conclusion：The effect of misoprostol combined with oxytocin in the treatment of postpartum hemorrhage is very good,and it is worth promoting and applying.